Skip to main content
Veterinary Medicines

BioBos IBR marker inact., Suspension for injection

Authorised
  • Infectious Bovine rhinotracheitis virus, strain BIO-27, Inactivated

Product identification

Medicine name:
BioBos IBR marker inact., Suspension for injection
BioBos IBR marker inact. vakcina A.U.V.
Active substance:
  • Infectious Bovine rhinotracheitis virus, strain BIO-27, Inactivated
Target species:
  • Cattle
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Infectious Bovine rhinotracheitis virus, strain BIO-27, Inactivated
    1.00
    relative potency
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Milk
        0
        hour
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AA03
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:
  • Plastic Vial 1 x 50.0 Dose
  • Plastic Vial 1 x 25.0 Dose
  • Glass Vial 1 x 50.0 Dose
  • Glass Vial 1 x 25.0 Dose
  • Glass Vial 1 x 5.0 Dose
  • Glass Vial 10 x 5.0 Dose

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • National Food Chain Safety Office
Authorisation number:
  • 3463/X/14 NÉBIH ÁTI
Date of authorisation status change:
Reference member state:
  • Czechia
Procedure number:
  • CZ/V/0120/001
Concerned member states:
  • Bulgaria
  • Estonia
  • Hungary
  • Latvia
  • Lithuania
  • Poland
  • Romania
  • Slovakia
  • Slovenia
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."